Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6790
+0.0184 (2.79%)
Oct 2, 2026, 2:39 PM EDT - Market open
Envoy Medical Earnings Call Transcripts
Fiscal Year 2026
-
A fully implanted cochlear implant with unique sensor and battery design targets a large, underserved U.S. market. Clinical trials are fully enrolled, with FDA submission planned for next year and potential approval by late 2027. Strong IP, first-mover status, and strategic board additions position the company for significant disruption.
-
A fully implanted cochlear implant with unique sensor and chest battery aims to disrupt a large, underpenetrated market, offering invisible, 24/7 hearing and compatibility with wearables. Clinical trials are complete, FDA submission is planned for next year, and insurance coverage is in place.